Metabolic dysfunction-associated fatty liver disease in people living with HIV

Abstract The prevalence of metabolic risk factors and non-alcoholic fatty liver disease (NAFLD) is high among people living with HIV (PLWH). Data on the recently proposed definition of metabolic dysfunction-associated fatty liver disease (MAFLD) in PLWH receiving antiretroviral therapy (ART) remains...

Full description

Bibliographic Details
Main Authors: Maurice Michel, Christian Labenz, Angelo Armandi, Leonard Kaps, Wolfgang Maximilian Kremer, Peter R. Galle, Daniel Grimm, Martin Sprinzl, Jörn M. Schattenberg
Format: Article
Language:English
Published: Nature Portfolio 2023-06-01
Series:Scientific Reports
Online Access:https://doi.org/10.1038/s41598-023-32965-y